MedTrace Logo

Data Analysis and Evaluation of the Incidence of Life-threatening Ventricular Arrhythmias in Patients with Newly Diagnosed Cardiomyopathies of NICM or MI/CAD Origin PROTECTED from SCD by a WCD

NCT06883383 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19598

Last updated 2025-03-19

No results posted yet for this study

Summary

SCD-PROTECT is an epidemiological, observational, multicenter study to assess the incidence of sudden cardiac arrest/death (SCA/SCD) in patients with newly diagnosed non-ischemic cardiomyopathy or with myocardial infarction/coronary artery disease. Data on SCA/SCD risk in the early phase of disease, especially during medication up-titration while left ventricular ejection fraction is reduced, are sparse.

Conditions

  • Cardiomyopathy (Ischemic or Non-Ischemic)

Sponsors & Collaborators

  • Zoll CMS GmbH

    collaborator UNKNOWN

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Johann Bauersachs, MD · Hannover Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06883383 on ClinicalTrials.gov